| 000 | 01647 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517013253.0 | ||
| 264 | 0 | _c20150513 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.114.008210 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRivkin, Michael J | |
| 245 | 0 | 0 |
_aThrombolysis in pediatric stroke study. _h[electronic resource] |
| 260 |
_bStroke _cMar 2015 |
||
| 300 |
_a880-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 |
_aCardiology _xmethods |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xmethods |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _adeVeber, Gabrielle | |
| 700 | 1 | _aIchord, Rebecca N | |
| 700 | 1 | _aKirton, Adam | |
| 700 | 1 | _aChan, Anthony K | |
| 700 | 1 | _aHovinga, Collin A | |
| 700 | 1 | _aGill, Joan Cox | |
| 700 | 1 | _aSzabo, Aniko | |
| 700 | 1 | _aHill, Michael D | |
| 700 | 1 | _aScholz, Kelley | |
| 700 | 1 | _aAmlie-Lefond, Catherine | |
| 773 | 0 |
_tStroke _gvol. 46 _gno. 3 _gp. 880-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.114.008210 _zAvailable from publisher's website |
| 999 |
_c24557584 _d24557584 |
||